jump to content jump to footer
Prof. Dr. Timm Denecke discusses AI-based early detection of liver cancer at RÖKO 2026

Predicting hepatocellular carcinoma (HCC) before it develops: Artificial Intelligence meets MRI

At RÖKO 2026, we spoke with Prof. Dr. Timm Denecke, Director of Radiology at Leipzig University Hospital, about RACOON-MARDER, a research project using artificial intelligence to detect the earliest imaging signs of hepatocellular carcinoma (HCC) in high-risk patients. By training AI on structured MRI data from across Germany's university hospitals, the project aims to identify which patients truly need intensive screening — and catch liver cancer before it becomes cancer. Mint Medical is proud to support this research as a technical network partner.

Read the full interview to find out how AI could reshape liver cancer screening.

Or watch the video interview with Prof. Denecke on Youtube. 

Success Story Clinical Routine MRI HCC RACOON AI

Related Resources

Radiologist using mint Lesion for structured lung cancer screening reporting and AI-assisted lung nodule assessment
How mint Lesion supports radiologists in the German lung cancer screening program through structured reporting, AI-supported workflows, second reading, and longitudinal patient follow-up.
Lung Cancer Screening in Germany: How mint Lesion Supports Radiologists in Clinical Practice
A New Era of Early Detection — and New Challenges With the introduction of the nationwide lung cancer screening program starting in 2026,…
Woman watching the Mint Medical and contextflow webinars on lung cancer screening in Germany on Youtube
Webinar series to explore different aspects of lung cancer screening in Germany
Webinar Series: Lung Cancer Screening in Germany - From Evidence to Implementation
Lung cancer remains one of the leading causes of cancer-related mortality worldwide. In Germany, the introduction of a national lung cancer screening…
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?